What question did this study set out to answer?

This research aims to evaluate user engagement and acceptability of digital therapeutics in self-monitoring of blood glucose.

April 15, 2026Open Access

Improving Diabetes Self management Using Digital Therapeutics: Insights into User Engagement from a Randomized Controlled Trial in Urban Aligarh

View Full Paper

Ask AI

Bookmark

This research aims to evaluate user engagement and acceptability of digital therapeutics in self-monitoring of blood glucose.
Conducted a randomized controlled trial in urban Aligarh with 132 participants.
Participants were divided into three groups: no SMBG, SMBG thrice weekly, and digital feedback with SMBG.
Collected socio-demographic data and user engagement metrics from participants using mobile application rating score.
72.5% of participants using DTI with SMBG reported high engagement.
More than half rated the app between 2 and 3 on acceptability parameters.
Identified common difficulties: security concerns (59%), user issues (26%), and technical problems (15%).

No takes yet. Share an insight, caveat, or question.

Randomized controlled trial assesses user engagement with digital therapeutics in diabetes management, suggesting valuable clinical applications.

Chelsea et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

Randomized controlled trial assesses user engagement with digital therapeutics in diabetes management, suggesting valuable clinical applications.